[CLINICAL EXPERIMENTATION OF TVA 841 IN THE TREATMENT OF HYPERCHOLESTEROLEMIA (APROPOS OF 30 OBSERVATIONS)].
D000924:Anticholesteremic Agents; D001162:Arteriosclerosis Obliterans; D035843:Biomedical Research; D002756:Cholagogues and Choleretics; D004358:Drug Therapy; D006331:Heart Diseases; D006429:Hemiplegia; D006801:Humans; D006937:Hypercholesterolemia; D006973:Hypertension; D013963:Thyroid Hormones; D014801:Vitamin A
D000924:Anticholesteremic Agents; D002756:Cholagogues and Choleretics; D013963:Thyroid Hormones; D014801:Vitamin A
ANTICHOLESTEREMIC AGENTS; ARTERIOSCLEROSIS OBLITERANS; CHOLAGOGUES AND CHOLERETICS; CLINICAL RESEARCH; DRUG THERAPY; HEART DISEASES; HEMIPLEGIA; HYPERCHOLESTEREMIA; HYPERTENSION; THYROID HORMONES; VITAMIN A
EXP'ERIMENTATION CLINIQUE DU T.V.A. 841 DANS LE TRAITEMENT DES HYPERCHOLEST'EROL'EMIES (A PROPOS DE 30 OBSERVATIONS)